I'd like to thank our presenters for being here this morning. We seem to be going around and around with this issue of post-market surveillance, and we hear a lot of different things.
My first question is going to be, who should be defining adverse effects? We have different definitions of what we're talking about.
Does anybody want to answer that? And what do you think that definition should be?